The effect of vitamin C on the risk of mortality in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Open Access
- 18 April 2023
- journal article
- review article
- Published by Springer Nature in Inflammopharmacology
- Vol. 31 (6) , 3357-3362
Abstract
Background and Aims Vitamin C appears to be a viable treatment option for patients with COVID-19. Methods We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) of vitamin C versus comparative interventions in patients with COVID-19. The outcome of interest was all-cause mortality. Results The meta-analysis of eleven trials using a random-effects model revealed significant reduction in the risk of all-cause mortality with the administration of vitamin C among patients with COVID-19 relative to no vitamin C (pooled odds ratio = 0.53; 95% confidence interval 0.30–0.92). Subgroup analysis of studies that included patients with severe COVID-19 also produced findings of significant mortality reduction with the administration of vitamin C relative to no vitamin C (pooled odds ratio = 0.47; 95% confidence interval 0.26–0.84). Conclusion Overall, evidence from RCTs suggests a survival benefit for vitamin C in patients with severe COVID-19. However, we should await data from large-scale randomized trials to affirm its mortality benefits.Keywords
This publication has 10 references indexed in Scilit:
- Efficacy of intravenous vitamin C in management of moderate and severe COVID-19: A double blind randomized placebo controlled trialJournal of Family Medicine and Primary Care, 2022
- High-dose Intravenous Vitamin C in Early Stages of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJournal of Research in Pharmacy Practice, 2022
- Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical TrialInternational Journal of Environmental Research and Public Health, 2022
- The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical TrialFrontiers in Immunology, 2021
- The effect of supplementation with vitamins A, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: a randomized clinical trialTrials, 2021
- Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trialEuropean Journal of Medical Research, 2021
- Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 InfectionJAMA Network Open, 2021
- Pilot trial of high-dose vitamin C in critically ill COVID-19 patientsAnnals of Intensive Care, 2021
- The Role of Vitamin C as Adjuvant Therapy in COVID-19Cureus, 2020
- Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trialJournal of Allergy and Clinical Immunology, 2020